Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04199078` - Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.	N/A
Active, not recruiting	`NCT02135419` - Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions	Phase 3
Active, not recruiting	`NCT02258659` - Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer	Phase 2
Completed	`NCT02714114` - Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)	N/A
Completed	`NCT00303823` - Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia	Phase 2
Not yet recruiting	`NCT05510830` - Diagnostic Cervical Conization for Persistent Infection or Integration of HPV	N/A
Completed	`NCT04002154` - Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV	N/A
Not yet recruiting	`NCT06123533` - Understanding Women's Values in Managing Human Papillomavirus (HPV)
Completed	`NCT04624568` - Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance	N/A
Completed	`NCT05694728` - A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine	Phase 2
Completed	`NCT04391647` - Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples
Recruiting	`NCT05439083` - Immunogenicity of 9-valent HPV Vaccine	Phase 4
Completed	`NCT01446198` - Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System	N/A
Completed	`NCT01539668` - Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas	Phase 0
Recruiting	`NCT06467942` - Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection	N/A
Completed	`NCT02811367` - The HPV Self-test as a Test of Cure in Madagascar	N/A
Completed	`NCT02067507` - Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County	N/A
Recruiting	`NCT01387997` - e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses	N/A
Completed	`NCT02634190` - Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens
Completed	`NCT00054041` - Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia	Phase 2

NCT number	NCT01567813
Study type	Observational
Source	Merck Sharp & Dohme LLC
Contact
Status	Completed
Phase
Start date	June 23, 2011
Completion date	June 1, 2019

Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms